Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.06 | 1.93 |
NAV | ₹20.69 | ₹412.51 |
Fund Started | 06 Oct 2020 | 04 Jun 1999 |
Fund Size | ₹170.77 Cr | ₹3989.42 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.06
1.93
NAV
₹20.69
₹412.51
Fund Started
06 Oct 2020
04 Jun 1999
Fund Size
₹170.77 Cr
₹3989.42 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
1 Year | 8.53% | -0.01% |
3 Year | 18.71% | 23.14% |
5 Year | 12.98% | 15.48% |
1 Year
8.53%
-0.01%
3 Year
18.71%
23.14%
5 Year
12.98%
15.48%
Equity | 99.94% | 96.59% |
Cash | -0.10% | 3.34% |
Equity
99.94%
96.59%
Cash
-0.10%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.98% |
Eli Lilly And Co | 6.97% |
Cipla Ltd. | 5.69% |
Max Healthcare Institute Ltd. | 5.41% |
Divi's Laboratories Ltd. | 5.08% |
Apollo Hospitals Enterprise Ltd. | 5.05% |
Dr. Reddy's Laboratories Ltd. | 4.59% |
Johnson & Johnson Ltd. | 4.02% |
Lupin Ltd. | 3.53% |
AbbVie Inc | 3.25% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 06 Oct 2020 | 04 Jun 1999 |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
06 Oct 2020
04 Jun 1999